Skip to content 
When a person or couple begins to learn about surrogacy, one of the first questions that arises is direct and understandable: what does success really depend on?
Behind that question lies a legitimate concern. The process involves highly significant medical, emotional, and legal decisions. And, in the clinical setting, one of the most crucial factors is embryo quality.
But what exactly does it mean for an embryo to be of “good quality”? How is it measured? What real relationship does it have with live pregnancy rates? And to what extent can it influence the outcome when surrogacy is used?
In this article, we will rigorously and clearly analyze the current medical criteria used by assisted reproduction clinics to evaluate embryos and how these criteria impact the chances of success. If you are just beginning to learn about fertility treatments, this content will help you understand the scientific basis without unnecessary technical jargon.
Join us until the end: understanding how an embryo is evaluated can completely change your perspective on the process.
Why embryo quality is a cornerstone of surrogacy
In any assisted reproduction treatment, the embryo is the biological starting point of pregnancy. In surrogacy, although the surrogate does not contribute genetic material, the transferred embryo does contain the genetic material of the intended parents or donors.
The success of the treatment depends on multiple variables:
- Age and reproductive health of those who provide the gametes.
- Fertilization technique used (conventional IVF or ICSI).
- Conditions of the embryology laboratory.
- State of the surrogate’s endometrium.
- Immunological and hormonal factors.
However, among all these factors, embryo quality acts as an initial biological filter. An embryo with structural or chromosomal abnormalities is less likely to implant successfully or develop into a viable pregnancy.
Therefore, when we talk about success rates in surrogacy, we are not only talking about the uterus that receives the embryo, but also about the intrinsic biological potential of the embryo itself.
What exactly is embryo quality?
Embryonic quality is a morphological and, in many cases, genetic evaluation of the embryo developed in the laboratory after fertilization.
This is not a subjective opinion. There are standardized medical criteria that embryologists use to classify embryos according to their implantation potential.
This evaluation is carried out at different stages of development:
- Day 2–3 (segmentation phase)
- Day 5–6 (blastocyst stage)
Today, blastocyst stage transfer is the most common practice in surrogacy programs, as it allows for more precise embryo selection.
Morphological evaluation at an early stage
During the first few days after fertilization, something fascinating and silent occurs: the embryo begins to divide steadily. These first cells, called blastomeres, multiply at a very precise rate. In the laboratory, embryologists closely observe this process because important clues about its development can be found in these small initial details.
At this early stage, it’s not simply a matter of counting cells. The analysis examines whether the number of blastomeres corresponds to the exact day of development, whether the cells maintain a similar shape and size, whether cytoplasmic fragmentation is present—small cellular remnants that may indicate less than optimal development—and whether multinucleation appears , a finding that can affect evolutionary potential.
When an embryo has an adequate number of cells, good symmetry, and minimal fragmentation, it is considered to have good early-stage quality. This is an initial indication of its potential.
However, this initial picture doesn’t reveal everything. Two embryos can appear virtually identical under a microscope and yet have chromosomal differences that are not visible to the naked eye. That is one of the major limitations of early screening: it offers valuable, but incomplete, information.
For this reason, current practice prioritizes analysis at a later stage, when the embryo reaches the blastocyst stage .
Around day 5 or 6 of development, the embryo takes a crucial step: it ceases to be a compact cluster of cells and begins to organize itself into differentiated structures. It is at this point that two fundamental components appear. On the one hand, the inner cell mass, which will give rise to the future baby. On the other, the trophectoderm , which will form the placenta and allow connection with the pregnant organism.
At this stage, the assessment of embryo quality becomes more precise. Classification systems such as Gardner’s analyze the degree of blastocyst expansion and independently evaluate the quality of both the inner cell mass and the trophectoderm . Thus, a classification like 4AA is not an arbitrary label: it indicates a well-expanded blastocyst with an excellent appearance in both key structures.
In surrogacy programs, this moment marks a turning point. The selection of the embryo with the greatest implantation potential is based on this detailed evaluation. It’s not merely an aesthetic matter under a microscope, but an assessment grounded in medical criteria that seeks to maximize the chances of that embryo continuing its development, implanting correctly, and progressing to a healthy pregnancy.
The role of preimplantation genetic testing (PGT)
Morphological evaluation does not detect chromosomal abnormalities. For this reason, many clinics incorporate preimplantation genetic testing (PGT-A) to analyze the embryo’s chromosomal makeup.
This study allows the identification of euploid embryos (with the correct number of chromosomes) and aneuploid embryos (with numerical alterations).
Why is it relevant in surrogacy?
Because even a morphologically perfect embryo can have chromosomal abnormalities that reduce the likelihood of implantation or increase the risk of early miscarriage.
Select chromosomally normal embryos:
- Improves the implementation rate.
- It reduces the likelihood of pregnancy loss.
- Optimize the number of transfers required.
Not all cases require PGT-A, but in contexts of advanced maternal age or a history of previous failures, its clinical utility is significant.
In our previous article we already delved deeper into this aspect and also analyzed:
Everything you need to know about Preimplantation Genetic Diagnosis (link to previous blog).
Is embryo quality everything?
This is where it’s worth pausing for a moment and putting things into perspective.
Embryo quality is undoubtedly a determining factor. But it doesn’t operate in isolation, as if everything depended solely on a laboratory classification. In surrogacy, the final result reflects a much larger system, where each piece must fit together precisely.
One of the most influential factors is the age of the egg donor. This isn’t just a number on a medical document. Biologically, egg age directly impacts the probability of obtaining chromosomally normal embryos. With increasing age, the rate of chromosomal abnormalities rises, which can reduce the chances of implantation or increase the risk of miscarriage. Therefore, this information is always carefully analyzed from the very beginning of the process.
Next, an element that often goes unnoticed by those just starting to learn about embryo transfer comes into play: the quality of the laboratory. The conditions in which the embryo is cultured—the incubators, the culture media, and the control of temperature, pH, and gases—are not minor details. They are critical variables that directly influence whether an embryo reaches the blastocyst stage under optimal conditions. The experience of the embryology team and the protocols applied can make a real difference in the results.
Then there’s the environment where that embryo will be transferred. Even an excellent embryo needs a receptive endometrium to implant. In surrogacy programs, the surrogate’s medical evaluation is carried out precisely to ensure that her uterine health is adequate and that the endometrial lining is prepared to receive the embryo at the right time. Nothing is left to chance.
And here another key point emerges: the synchronization between the embryo and the endometrium. There is a specific period known as the “implantation window,” during which the uterus is especially receptive. If the transfer is not timed with the correct hormonal preparation and the precise moment of embryonic development, the chances of success can be compromised. It is a delicate balance that requires medical precision.
Therefore, although embryo quality is an important predictor in surrogacy, success does not depend on a single factor. It is the result of multiple variables working in harmony: biology, technology, clinical experience, and personalized planning. When each element is carefully coordinated, the odds are significantly optimized.
Success rates: how to interpret them correctly
One of the most common mistakes when starting to research assisted reproduction is to be swayed by percentages without understanding what they actually measure. The numbers, on their own, may seem compelling. But if we don’t know what they represent, they can generate unrealistic expectations or inaccurate comparisons.
In reproductive medicine, success rates don’t always mean the same thing. Some clinics talk about the implantation rate per embryo transferred, that is, how many embryos successfully attach to the endometrium after transfer. Others focus on the clinical pregnancy rate, which is confirmed by ultrasound by detecting a gestational sac and heartbeat. The viable pregnancy rate may also be mentioned, which refers to when the pregnancy survives the critical first weeks. And finally, there is the live birth rate, which is the most comprehensive indicator because it reflects that the process culminated in the birth of a baby.
In the context of surrogacy, this last piece of data is truly relevant. More specifically, the live birth rate per euploid embryo transfer . This combination of variables—live birth and chromosomally normal embryo—offers a much more realistic benchmark of the treatment’s potential.
Generally speaking, and without going into specific figures because they can vary depending on the clinic, the age of the gametes, and the medical profile, euploid embryos at the blastocyst stage tend to have significantly higher probabilities of a successful pregnancy compared to those that have not undergone genetic analysis. This does not mean that other embryos cannot result in a healthy pregnancy, but rather that chromosomal selection helps optimize the odds and reduce certain risks.
However, even under the most advanced medical standards, no treatment can offer an absolute guarantee. Reproductive biology retains an unpredictable component. Implantation is a complex process involving cellular and molecular mechanisms that we still do not fully understand.
Therefore, when analyzing surrogacy success rates, the most important thing is not to find the highest number, but to understand exactly what it measures and how it applies to each individual situation. Only then do the numbers cease to be abstract promises and become useful information for making informed and calm decisions.
Current innovations in embryo assessment
Reproductive medicine is constantly evolving. Today, in addition to traditional evaluation, there are complementary technologies:
Embryonic time- lapse
It allows for continuous monitoring of embryo development without removing it from the incubator. Cell division patterns associated with higher implantation potential are analyzed.
Artificial intelligence in embryology
Some systems use algorithms to predict embryonic potential based on thousands of previous cycles.
Metabolomics analysis
It studies the consumption of nutrients and metabolic production of the embryo.
These tools do not replace traditional evaluation, but they can provide additional information in the selection process within a surrogacy program.
What happens when embryo quality is not optimal?
Not all cycles produce high-grade blastocysts . This does not automatically mean that the treatment is doomed to failure.
There are medical strategies that can improve results in subsequent cycles:
- Adjustments in ovarian stimulation.
- Changes in laboratory protocols.
- Use of egg donation when medically indicated.
- Individualized transfer according to medical history.
The key is to analyze each case individually and not rely solely on an isolated embryonic classification.
The balance between science and hope
In the field of surrogacy, it’s perfectly natural to seek certainty. When we talk about starting a family, we want guarantees, clear answers, and reassuring percentages. However, human reproduction doesn’t follow exact mathematical formulas. Even with current advances, it remains a complex biological process, partly predictable and partly unpredictable.
Embryo quality increases the odds, but it doesn’t guarantee results. That distinction is crucial. A blastocyst classified as excellent may not implant, while one with an intermediate rating may develop without complications until birth. Classification guides, optimizes decisions, and reduces risks, but it doesn’t make biology a perfect equation.
Understanding this reality is not discouraging; on the contrary, it is liberating. It allows you to adjust expectations, avoid unnecessary frustrations, and approach the process with a solid foundation of information. When you understand how probabilities truly work, each step is experienced with greater serenity.
If you’re in the research phase, a medical consultation shouldn’t be limited to hearing general percentages. It’s time to delve deeper and understand the underlying clinical approach. Asking what criteria they use to classify embryos will give you an idea of the level of precision in their selection. Knowing if they work with blastocyst -stage transfers allows you to assess the laboratory’s standards. Asking in which cases they recommend PGT-A helps you understand if the indication is personalized or protocol-driven. Inquiring about the live birth rate per euploid embryo transferred provides a more realistic benchmark than other intermediate figures. And asking how they select the surrogate to optimize endometrial receptivity reveals the level of comprehensive medical evaluation of the program.
Having clarity on these points completely changes how success rates are interpreted. It’s no longer just about numbers, but about understanding what lies behind them.
Because, ultimately, the true meaning of “success” in surrogacy goes far beyond a percentage. It’s not just about achieving a positive test result. It involves a safe pregnancy, rigorous medical monitoring, reduced obstetric risks, and, finally, the birth of a healthy baby.
Embryo quality represents the first biological step toward that goal. It’s the beginning of the journey. But for that journey to reach its destination, something more comprehensive is needed: multidisciplinary medical coordination, well-established protocols, clinical expertise, and continuous support. When all these elements work together, the concept of success acquires its true meaning.
Conclusion: Information as a tool for peace of mind
The process ceases to seem like a complete mystery when you understand how an embryo is evaluated and what factors truly affect success rates in surrogacy.
Modern reproductive science has sophisticated tools for identifying embryos with high potential. However, each case is unique and must be examined individually. If you are in the early stages of your research, understanding these basic concepts will enable you to ask more effective questions, analyze data with discernment, and move forward with greater confidence. And that, in truth, is the foundation of any informed decision.
FAQs about embryo quality and surrogacy
- Does an excellent quality embryo guarantee pregnancy?
No. It significantly increases the chances of implantation, but it cannot guarantee the result, as other biological factors are involved.
- Is preimplantation genetic diagnosis mandatory?
Not in all cases. It is especially recommended when there is advanced maternal age, recurrent miscarriages, or previous implantation failures.
- Does the surrogate’s age influence whether the embryo is of good quality?
Yes. Even if the embryo is optimal, uterine health and the mother’s age influence the course of the pregnancy.
- Can embryo quality be improved?
It is not possible to modify an embryo that has already been created, but it is possible to optimize stimulation protocols and laboratory conditions in future cycles.
- Can an embryo of intermediate quality result in a healthy baby?
Yes. Morphological classification provides guidance on probabilities, but does not absolutely determine the final result.
- Why is blastocyst transfer preferred in surrogacy?
Because they allow for more precise selection and synchronize better with the endometrium, increasing the implantation rate.
- How many embryos are usually transferred?
Currently, the trend is to transfer a single embryo to reduce the risk of multiple pregnancy and its possible complications.
